Ulaizer — the best method of treatment of respiratory diseases

10 December 2013

We represent you a range of pressured nebulizers produced by domestic manufacturer YURiA-PHARM corporation, called Ulaizer.

Nebulizer therapy is used as an integral part of the treatment of diseases such as:

Nebulizer (sprayer) is a device that converts the drug solution into a cloud of mist (aerosol) of small particles for inhalation. The aim of the nebulizer therapy is to deliver therapeutic doses of the desired drug into the respiratory tissues over a short period of time (5-10 min).

img_ulaizer_homeIn the following circumstances Nebulizer is the device of choice:

  • A rapid onset of effect is required
  • Concomitant use of several drugs
  • Inhalation of large doses of the drug is required
  • Children aged below 5 years
  • Elderly people
  • Condition of patients or their skills do not allow them to coordinate the use of different devices for administering medicines
  • The patients in the postoperative period
  • Patients on artificial lung ventilation

Benifits of the nebulizer therapy:

  • Creation of a high concentration of the drug in respiratory tract
  • Easy inhalation technique – no need of breath coordination with the delivery of the aerosol
  • Possibility of application in severe conditions (status asthmaticus), in elderly patients, children, unconscious patients
  • Maximization of activity of the pharmaceutical drugs through action on the large surface area of the respiratory tract
  • The absence of a traumatic impact on the child’s psyche
  • Possibility of long-term exposure
  • The fraction of the drug deposited in the oropharynx, is negligible
  • Reduction of the total dose
  • Allows to lower the dose of oral, intravenous GC or completely discontinue them
  • Absence of systemic effects of the drug
  • The aerosol does not contain propellants
  • Comfortable use
  • Reduces the risk of hospitalization by 2 times
  • Reduces the risk of re-visit the doctor by 5 times
  • Significantly reduce the cost of patient care

For effective delivery of drugs in respiratory organs the aerosol particle diameter should be:

  • 1-5 μm – the bronchi
  • 5-10 μm – pharynx, larynx, trachea
  • 0.5-1 μm – the alveoli

The optimum particle size – 4 μm. Nebulizer therapy is a modern way to deliver the drug to the respiratory tract, the efficacy and safety of its application is scientifically proven, including in persons with severe somatic pathology and in children. In some cases, the use of nebulizers is the only method providing drug delivery directly into the target organ.